Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 268-610-1 | CAS number: 68131-13-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The repeated dose toxicity of NA-DETA can be reasonably derived by available data on NA-DETA and read-across to naphthenic acids. Liver toxicity together with related systemic effect is expected upon prolonged exposure to NA-DETA. The NOAEL of 6 mg/kg bw for subchronic toxicity of NA-DETA is considered to be valid.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- NOAEL
- 6 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
- Quality of whole database:
- The available data comprise one 14-day repeated dose toxicity study on NA-DETA and one combined repeated dose toxicity with reproduction/developmental toxicity sceening study on naphthenic acid and one subchronic toxicity study on naphthenic acid. All three studies are considered to be of equal value for the chronic toxicity assessment of NA-DETA.
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
The repeated dose toxicity of NA-DETA is derived based on the available data on NA-DETA and the read-across using naphthenic acid as source chemical.
Analog Approach Justification (target chemical: NA-DETA, source chemical: naphthenic acid):
Based on the general biotransformation principles three pathways can be reasonably predicted: a) NA-DETA undergoes enzymatic hydrolysis at amide/imide bond; b) NA-DETA undergoes oxidative N-dealkylation at amide/imide bond, followed by deamination; c) NA-DETA undergoes oxidative N-dealkylation at secondary amine, followed by deamination/oxidation. The result of these introduced pathways is release of naphthenic acid, so that the systemic exposure to naphthenic acid can be derived as toxicity mode of action.
Mode of action of NA-DETA upon prolonged exposure
Two types of mode of action of NA-DETA can be derived:
- local irritation effect on tissues nearby to the portal of entry
- systemic exposure to naphthenic acids.
The local effects is expected to predominate at rather higher exposure dose levels while effect due to the systemic exposure to naphthenic acids is expected to become more distinctive as the exposure period increases.
According to the preliminary cytotoxicity data in genotoxicity studies (chromosome aberration test and gene mutation test in mammalian cells) NA-DETA is cytotoxic to mammalian cells. Further supporting evidences are that NA-DETA is irritating to skin and eyes. In the 14 -day repeated dose toxicity study in rats mortality occurred at dose levels of 500 mg/kg bw and higher and distinctive changes in the gastro intestinal tract was found in dead animals.
Upon exposure to NA-DETA the tissues nearby to the portal of entry are expected to be the target organ, which means the gastro-intestinal tract, respiratory tract or contact site of skin depending on the exposure routes. The local effect may comprise tissue damage, inflammatory response and poor general health conditions. The reproduction performance may also be affected, but as of secondary nature.
In the 14-day repeated dose toxicity study in rats using NA-DETA as test material no evident toxic effect was observed at dose levels of 100 mg/kg bw and below. The NOAEL of 100 mg/kg bw for irritation effect can be considered to be valid for long-term exposure, since the local irritation effect is a matter of concentration but not of the total systemic exposure level.
At dose levels not associated to local irritation effect the systemic exposure to naphthenic acid may become more important.
The commercial naphthenic acid was investigated according to OECD Guideline 422. The treatment related effects were found in liver, kidney, thyroid and adrenals. Further the red blood cell count for males and the white blood cell count for females were altered, indicating systemic inflammation status.
The naphthenic acid from Canadian oil sands tailings was investigated for its subchronic toxicity using female rats. At dose level of 60 mg/kg bw the liver was found as target organ and the author postulated the induction of hepatic detoxification enzymes as underlying mechanism.
Both studies are indicating the liver as target organ and metabolic overload as underlying mechanism, which should be applicable for the prediction of repeated dose toxicity of NA-DETA. Upon repeated exposure to NA-DETA at dose levels not associated to local irritation effect, liver toxicity is expected to occur together with systemic effect related to metabolic overload.
Comments on the use of the NOAEL of 6 mg/kg bw to derive the DNEL for NA-DETA.
The liver effect found in the OECD 422 study at 300 mg/kg bw is of adaptive nature, whereas the liver effect found in the subchronic toxicity study at 60 mg/kg bw is to be assessed as adverse. The enhanced liver effect found in the subchronic toxicity study can be explained as the synergic combination of increased amount of multiple fused ring components with prolonged exposure duration.
Because the target chemical NA-DETA is the reaction mass of the commercial naphthenic acid, the use of 6 mg/kg bw to derive the DNEL is a very conservative approach, resulting into the overestimation of toxicity of NA-DETA. No further assessment factor related to the read-across uncertainly is justified.
Justification for not taking account the observed seizure for hazard assessment of NA-DETA
In the subchronic toxicity study using naphthenic acid from the Canadian oil sands tailings as test material the seizure was observed for animals treated at dose levels of 6 and 60 mg/kg bw. Such effect was not observed in other repeated dose studies using commercial naphthenic acid as test material and seems to be specific to naphthenic acids originating from Canadian oil sands tailings. Also the acute toxicity profile for naphthenic acids originating from oil sands tailings comprised lethargy and ataxia and differed to those of other commercial ones (The American Petroleum Institute, Consortium Registration #1100997, 2012).
Therefore, the observed neurotoxicity indication is considered of limited relevance for the hazard assessment of NA-DETA, because NA-DETA is the reaction mass of the commercial naphthenic acids.
Justification for selection of repeated dose toxicity via oral route - systemic effects endpoint:
Weight of evidence approach is used for the endpoint repeated dose toxicity.
Justification for classification or non-classification
The availabld data on NA-DETA as well as on read-across surrogated napthenic acid support non-classification for the endpoint repeated dose toxicity.
No classification is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.